“…Inhibition of B. asper Mytotoxin II by Suramin attempted to identify and to delineate the region or regions important for the expression of myotoxicity in PLA 2 s, 23 on the basis of sequence homology, [36][37][38] charge distribution, [39][40][41] hydrophobicity profiles, 39 chemical modification, 42,43 use of synthetic peptides, 34,44,45 and site-directed mutagenesis. 30,46 With the biochemical and structural information currently available we are now able to probe the structure-function relationship, and the mode of action and inhibition of Lys49 PLA 2 analogues by addressing the roles of the C-terminal region and the nominal active site in myotoxicity.…”